tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALRN Stock Latest News

Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
Press ReleasesAileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
1M ago
ALRN
Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)
PremiumThe Fly
Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)
1M ago
ALRN
Aileron Therapeutics to be included in Russell Microcap Index
PremiumThe Fly
Aileron Therapeutics to be included in Russell Microcap Index
3M ago
ALRN
Aileron Therapeutics initiated with a Buy at Brookline
PremiumThe Fly
Aileron Therapeutics initiated with a Buy at Brookline
4M ago
ALRN
Aileron Therapeutics Announces New Interim CFO Appointment
PremiumCompany Announcements
Aileron Therapeutics Announces New Interim CFO Appointment
4M ago
8K
ALRN
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
PremiumPress ReleasesAileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
4M ago
ALRN
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
Premium
Press Releases
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
5M ago
ALRN
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
Premium
Press Releases
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
5M ago
ALRN
Aileron Therapeutics 4.27M share Direct Listing priced at $4.68
PremiumThe Fly
Aileron Therapeutics 4.27M share Direct Listing priced at $4.68
5M ago
ALRN
Aileron Therapeutics prices 4.27M shares at $4.68 in registered direct offering
PremiumThe Fly
Aileron Therapeutics prices 4.27M shares at $4.68 in registered direct offering
5M ago
ALRN
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
PremiumPress Releases
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
5M ago
ALRN
Aileron Therapeutics announces data from Cohort 1 of Phase 1b trial of LTI-03
PremiumThe Fly
Aileron Therapeutics announces data from Cohort 1 of Phase 1b trial of LTI-03
5M ago
ALRN
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
PremiumPress ReleasesAileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
5M ago
ALRN
Aileron Therapeutics price target raised to $19 from $9 at Ladenburg
Premium
The Fly
Aileron Therapeutics price target raised to $19 from $9 at Ladenburg
5M ago
ALRN
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Premium
Press Releases
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
5M ago
ALRN
Aileron Therapeutics Announces CFO Transition and Appointment
PremiumCompany Announcements
Aileron Therapeutics Announces CFO Transition and Appointment
6M ago
8K
ALRN
Aileron Therapeutics Announces CEO Transition and Board Update
PremiumCompany Announcements
Aileron Therapeutics Announces CEO Transition and Board Update
6M ago
8K
ALRN
Aileron Therapeutics CEO Manuel Aivado steps down, Brian Windsor to succeed
PremiumThe Fly
Aileron Therapeutics CEO Manuel Aivado steps down, Brian Windsor to succeed
6M ago
ALRN
Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success
PremiumCompany Announcements
Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success
7M ago
8K
ALRN
Aileron Therapeutics’ Shareholders Approve Major Stock Proposals
PremiumCompany AnnouncementsAileron Therapeutics’ Shareholders Approve Major Stock Proposals
7M ago
8K
ALRN
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
Premium
Press Releases
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
7M ago
ALRN
Aileron Therapeutics Grants COO Performance Bonus for 2023
Premium
Company Announcements
Aileron Therapeutics Grants COO Performance Bonus for 2023
7M ago
8K
ALRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >